Kewaunee Scientific Co. (NASDAQ:KEQU) CEO Thomas David Hull III Sells 1,844 Shares

Kewaunee Scientific Co. (NASDAQ:KEQU) CEO Thomas David Hull III sold 1,844 shares of the stock in a transaction that occurred on Monday, April 14th. The stock was sold at an average price of $32.44, for a total value of $59,819.36. Following the completion of the transaction, the chief executive officer now directly owns 36,072 shares of the company’s stock, valued at $1,170,175.68. This represents a 4.86 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Thomas David Hull III also recently made the following trade(s):

• On Monday, March 24th, Thomas David Hull III sold 3,000 shares of Kewaunee Scientific stock. The stock was sold at an average price of $45.63, for a total transaction of $136,890.00.
• On Friday, March 21st, Thomas David Hull III sold 213 shares of Kewaunee Scientific stock. The shares were sold at an average price of $48.53, for a total transaction of $10,336.89.

Kewaunee Scientific Stock Down 3.3 %

Shares of KEQU stock traded down $1.09 during mid-day trading on Monday, hitting $32.15. The company’s stock had a trading volume of 41,778 shares, compared to its average volume of 23,781. The company has a debt-to-equity ratio of 0.45, a quick ratio of 2.13 and a current ratio of 2.64. Kewaunee Scientific Co. has a 52-week low of $30.82 and a 52-week high of $71.33. The stock has a market cap of $91.79 million, a price-to-earnings ratio of 5.10 and a beta of 0.59. The business has a 50-day moving average price of $49.68 and a 200 day moving average price of $47.45.

Kewaunee Scientific (NASDAQ:KEQU) last issued its earnings results on Wednesday, March 12th. The technology company reported $1.09 earnings per share (EPS) for the quarter. The company had revenue of $67.17 million for the quarter. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%.

Wall Street Analysts Forecast Growth

Separately, StockNews.com lowered Kewaunee Scientific from a “buy” rating to a “hold” rating in a research report on Friday, March 14th.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the stock. Invesco Ltd. purchased a new stake in shares of Kewaunee Scientific during the fourth quarter worth about $6,545,000. Marshall Wace LLP purchased a new stake in Kewaunee Scientific during the 4th quarter valued at approximately $736,000. Truffle Hound Capital LLC bought a new stake in shares of Kewaunee Scientific during the fourth quarter valued at approximately $619,000. State Street Corp bought a new position in shares of Kewaunee Scientific during the third quarter worth $266,000. Finally, Janney Montgomery Scott LLC bought a new position in shares of Kewaunee Scientific during the fourth quarter worth $338,000. Institutional investors own 32.69% of the company’s stock.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.